Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | APAF1 | O14727 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | HK1 | P19367 | 1/20 | 0.33 |
| ▸ | GALK1 | P51570 | 1/20 | 0.33 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 2/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10689272 | 0.81 | IDO1 (0.34) | IDO1CYP1A2CYP2D6MAPTKDM4E | |
| SCHEMBL6731218 | 0.81 | MEN1 (0.46) | MAPTKDM4EMEN1KMT2AALDH1A1 | |
| SCHEMBL22130438 | 0.81 | ABCG2 (0.33) | — | |
| SCHEMBL4488526 | 0.81 | — | — | |
| SCHEMBL3173360 | 0.80 | IDO1 (0.31) | IDO1 | |
| SCHEMBL4137855 | 0.78 | CYP1A2 (0.31) | CYP1A2CYP2D6 | |
| SCHEMBL4138703 | 0.78 | — | — | |
| SCHEMBL17863803 | 0.78 | MBNL1 (0.33) | IDO1ACHE | |
| SCHEMBL16556384 | 0.78 | ACHE (0.33) | IDO1ACHE | |
| SCHEMBL15475376 | 0.77 | MEN1 (0.36) | MEN1KMT2AALDH1A1LMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 288 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119431405-B | Indolo [3,2-b ] carbazole dimer derivative, and preparation method and application thereof | 沈阳药科大学 | 2026-05-15 | — | — | CN | claimed |
| CN-122054890-A | Molecular assembly method of D-A type blending system and application thereof | 苏州工学院 | 2026-05-15 | — | — | CN | claimed |
| CN-119431405-A | Indolo [3,2-b ] carbazole dimer derivative, and preparation method and application thereof | 沈阳药科大学 | 2025-02-14 | — | — | CN | claimed |
| CN-118894862-A | Indolo [3,2-B ] carbazole structural derivative and electroluminescent device thereof | 西安欧得光电材料有限公司 | 2024-11-05 | — | — | CN | claimed |
| CN-114853763-B | D-pi-A compound and application thereof in passivation of perovskite solar cell | 大连理工大学 | 2023-06-09 | — | — | CN | claimed |
| CN-114853763-A | D-pi-A compound and application thereof in perovskite solar cell passivation | 大连理工大学 | 2022-08-05 | — | — | CN | claimed |
| WO-2022094174-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ESOPHAGEAL CONDITIONS | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 2022-05-05 | — | — | WO | claimed |
| US-20210060158-A1 | AGONIST OF ARYL HYDROCARBON RECEPTOR FOR USE IN CANCER COMBINATION THERAPY | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2021-03-04 | — | — | US | claimed |
| EP-3684410-A1 | AGONIST OF ARYL HYDROCARBON RECEPTOR FOR USE IN CANCER COMBINATION THERAPY | Institut Curie (FR) | 2020-07-29 | — | — | EP | claimed |
| WO-2019115576-A1 | METHODS OF TREATING HEART FAILURE | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2019-06-20 | — | — | WO | claimed |
| WO-2019057744-A1 | AGONIST OF ARYL HYDROCARBON RECEPTOR FOR USE IN CANCER COMBINATION THERAPY | INSTITUT CURIE (FR) | 2019-03-28 | — | — | WO | claimed |
| US-20180256617-A1 | METHODS FOR EXTENDING LIFESPAN AND METHODS OF SCREENING KNOWN PHARMACOLOGICAL AGENTS FOR NEW USES | LONGEVICA THERAPEUTICS INC. | 2018-09-13 | — | — | US | claimed |
| US-20160343960-A1 | Organometallic Complex, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2016-11-24 | — | — | US | claimed |
| WO-2016168670-A2 | METHODS FOR EXTENDING LIFESPAN AND METHODS OF SCREENING KNOWN PHARMACOLOGICAL AGENTS FOR NEW USES | LONGEVICA THERAPEUTICS INC. (US) | 2016-10-20 | — | — | WO | claimed |
| EP-1030663-B1 | TREATMENT OF FIBROMYALGIA AND RELATED DISORDERS | DESIGNED NUTRITIONAL PRODUCTS (US) | 2010-03-10 | — | — | EP | claimed |
| US-6613792-B1 | Treatment of premenstrual syndrome and menopause | DESIGNED NUTRITIONAL PRODUCTS, INC. | 2003-09-02 | — | — | US | claimed |
| EP-1030663-A4 | TREATMENT OF FIBROMYALGIA AND RELATED DISORDERS | DESIGNED NUTRITIONAL PRODUCTS (US) | 2002-06-26 | — | — | EP | claimed |
| WO-2001008637-A2 | TREATMENT OF PREMENSTRUAL SYNDROME AND MENOPAUSE | DESIGNED NUTRITIONAL PRODUCTS, INC. (US) | 2001-02-08 | — | — | WO | claimed |
| EP-1030663-A1 | TREATMENT OF FIBROMYALGIA AND RELATED DISORDERS | Designed Nutritional Products Inc. (US) | 2000-08-30 | — | — | EP | claimed |
| WO-1999017768-A1 | TREATMENT OF FIBROMYALGIA AND RELATED DISORDERS | DESIGNED NUTRITIONAL PRODUCTS, INC. (US) | 1999-04-15 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160343960-A1 | Organometallic Complex, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | CALCOCO2, CYBA, INTS9 | IDO1 244/4885CYP1A2 1386/4885CYP2D6 1850/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.